APA (7th ed.) Citation

Y, C., S, C., H, Z., B, S., & Y, X. (2026). The microbiota-lymphocyte protective axis (MLPA): A novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy. Cancer immunology, immunotherapy : CII, 75(9), . https://doi.org/10.1007/s00262-026-04442-8

Chicago Style (17th ed.) Citation

Y, Chen, Chen S, Zhang H, Song B, and Xu Y. "The Microbiota-lymphocyte Protective Axis (MLPA): A Novel Paradigm for Overcoming Radiation-induced Lymphopenia (RIL) and Potentiating the Efficacy of Tumor Immuno-combination Therapy." Cancer Immunology, Immunotherapy : CII 75, no. 9 (2026). https://doi.org/10.1007/s00262-026-04442-8.

MLA (9th ed.) Citation

Y, Chen, et al. "The Microbiota-lymphocyte Protective Axis (MLPA): A Novel Paradigm for Overcoming Radiation-induced Lymphopenia (RIL) and Potentiating the Efficacy of Tumor Immuno-combination Therapy." Cancer Immunology, Immunotherapy : CII, vol. 75, no. 9, 2026, https://doi.org/10.1007/s00262-026-04442-8.